This medication is used to treat a certain type of cancer (multiple myeloma). Isatuximab belongs to a class of drugs known as monoclonal antibodies. It works by slowing or stopping the growth of cancer cells.
How to use Sarclisa 20 Mg/Ml Intravenous Solution Antineoplastic - Anti-CD38 Monoclonal Antibody
Read the Patient Information Leaflet if available from your pharmacist before you start using isatuximab and each time you receive this medication. If you have any questions, ask your doctor or pharmacist.
This medication is given by injection into a vein by a health care professional. It is given as directed by your doctor on a treatment schedule, usually once a week for the first 4 weeks, then once every 2 weeks. Follow your doctor's treatment schedule carefully.
Isatuximab may cause serious infusion reactions during or within a day after treatment. Your doctor should prescribe other medications before each treatment to help prevent these side effects. Tell your doctor right away if you have any symptoms of infusion reactions such as nausea, shortness of breath, cough, headache, or chills.
The dosage is based on your weight and response to treatment.
To get the most benefit, do not miss any doses. To help you remember, mark the days on the calendar when you need to receive this medication.
See also How to Use section.
People using this medication may have serious side effects. However, your doctor has prescribed this drug because he or she has judged that the benefit to you is greater than the risk of side effects. Careful monitoring by your doctor may decrease your risk.
Tell your doctor right away if you have any serious side effects, including: easy bruising/bleeding, unusual tiredness.
This medication may lower your ability to fight infections. This may make you more likely to get a serious infection or make any infection you have worse. Tell your doctor right away if you have any signs of infection (such as sore throat that doesn't go away, fever, chills, cough, shortness of breath).
Some people treated with this medication may rarely get other cancers. Consult your doctor for more details.
A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Before using isatuximab, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
Before using this medication, tell your doctor or pharmacist your medical history, especially of: current/recent infection.
Isatuximab can make you more likely to get infections or may worsen any current infections. Avoid contact with people who have infections that may spread to others (such as chickenpox, measles, flu). Consult your doctor if you have been exposed to an infection or for more details.
To lower the chance of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports.
Tell your doctor if you are pregnant or plan to become pregnant. You should not become pregnant while using isatuximab. Isatuximab may harm an unborn baby. Ask about reliable forms of birth control while using this medication and for 5 months after stopping treatment. If you become pregnant, talk to your doctor right away about the risks and benefits of this medication.
When isatuximab is used in combination with pomalidomide, it must not be used during pregnancy. The combination may cause harm (possibly death) to an unborn baby. Talk to your doctor for more details. Females using these medications must use two reliable forms of birth control. Males using these medications must always use a condom during sexual activity. If you or your partner become pregnant, or if you think you or your partner may be pregnant, tell your doctor right away.
It is unknown if this drug passes into breast milk. Because of the possible risk to the infant (especially when using with pomalidomide), breast-feeding while using this drug is not recommended. Consult your doctor before breast-feeding.
Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval.
This medication may interfere with certain lab tests (such as Coombs test), possibly causing false test results. Make sure lab personnel and all your doctors know you use this drug.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call 911. Otherwise, call a poison control center right away. US residents can call their local poison control center at 1-800-222-1222. Canada residents can call a provincial poison control center.
Do not share this medication with others.
Lab and/or medical tests (such as complete blood count) should be done before you start using this medication and while you are using it. Keep all medical and lab appointments. Consult your doctor for more details.
Not applicable. This medication is given in a clinic and will not be stored at home.Information last revised March 2020. Copyright(c) 2020 First Databank, Inc.
Sorry. No images are available for this medication.
Are you taking Sarclisa 20 Mg/Ml Intravenous Solution Antineoplastic - Anti-CD38 Monoclonal Antibody?
Are you considering switching to Sarclisa 20 Mg/Ml Intravenous Solution Antineoplastic - Anti-CD38 Monoclonal Antibody?
How satisfied are you with the results?
Are you planning to see a doctor about switching your medication?
How long have you been taking Sarclisa 20 Mg/Ml Intravenous Solution Antineoplastic - Anti-CD38 Monoclonal Antibody?
Are you planning to see a doctor about switching your medication?
Thanks for taking our survey!
Recommended For YouFind a doctor near you